05/16/2024
5:05 AM | Cellectar Biosciences (Filer)
| Form DEFR14A | |
05/14/2024
5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
5:32 AM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
3:58 PM | Cellectar Biosciences (Filer)
| Form DEF 14A | |
04/26/2024
3:59 PM | Cellectar Biosciences (Filer)
| Form DEFA14A | |
04/25/2024
7:01 PM | Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
03/27/2024
5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/27/2024
5:30 AM | Cellectar Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
7:31 PM | Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
02/14/2024
2:23 PM | Cellectar Biosciences (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G/A | |
02/07/2024
5:58 PM | Cellectar Biosciences (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
02/02/2024
5:03 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
7:00 AM | ADAR1 Partners, LP (Filed by)
Cellectar Biosciences (Subject)
| Form SC 13G | |
01/09/2024
5:02 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
7:04 PM | CARUSO JAMES V (Reporting)
Cellectar Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:04 PM | Cellectar Biosciences (Issuer)
Longcor Jarrod (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:05 PM | Cellectar Biosciences (Issuer)
Shustov Andrei (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:07 PM | Cellectar Biosciences (Issuer)
Kolean Chad J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:09 PM | Cellectar Biosciences (Issuer)
Lea Darrell Shane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
4:15 PM | Cellectar Biosciences (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G | |
12/05/2023
5:01 AM | Cellectar Biosciences (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
11/29/2023
3:31 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
5:30 AM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
6:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
11:15 PM | Cellectar Biosciences (Filer)
| Form EFFECT | |
10/27/2023
3:40 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2023
3:54 PM | Cellectar Biosciences (Filer)
| Form S-3/A | |
10/05/2023
3:45 PM | Cellectar Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/02/2023
3:40 PM | Cellectar Biosciences (Filer)
| Form DEF 14A | |
09/22/2023
3:40 PM | Cellectar Biosciences (Filer)
| Form PRE 14A | |
09/22/2023
3:30 PM | Cellectar Biosciences (Filer)
| Form D
Notice of Exempt Offering of Securities | |
09/08/2023
4:17 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
3:30 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
7:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
7:30 AM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/29/2023
3:31 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
5:03 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
5:27 PM | Cellectar Biosciences (Issuer)
Swirsky Douglas J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
5:24 PM | Cellectar Biosciences (Issuer)
Chanan-Khan Asher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
5:24 PM | Cellectar Biosciences (Issuer)
DRISCOLL FREDERICK W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
5:25 PM | Cellectar Biosciences (Issuer)
Loren Stefan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Overlooked Retirement Asset You Probably Don’t Own (Ad) 4 out of 5 Americans believe we’re on the brink of a retirement crisis.
Luckily, in these unprecedented times, we have an unprecedented solution.
Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. |
06/28/2023
5:26 PM | Cellectar Biosciences (Issuer)
NEIS JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
5:08 AM | Cellectar Biosciences (Filer)
| Form 8-K/A | |
06/20/2023
5:09 AM | Cellectar Biosciences (Filer)
| Form DEFA14A | |
06/14/2023
3:25 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
3:27 PM | Cellectar Biosciences (Filer)
| Form DEFA14A | |
06/13/2023
3:30 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
